Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Derailed estrogen signaling and breast cancer: an authentic couple.

Manavathi B, Dey O, Gajulapalli VN, Bhatia RS, Bugide S, Kumar R.

Endocr Rev. 2013 Feb;34(1):1-32. doi: 10.1210/er.2011-1057. Epub 2012 Sep 4. Review.

2.

MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.

Lappano R, Santolla MF, Pupo M, Sinicropi MS, Caruso A, Rosano C, Maggiolini M.

Breast Cancer Res. 2012 Jan 17;14(1):R12.

3.

ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer.

Guttilla IK, Adams BD, White BA.

Trends Endocrinol Metab. 2012 Feb;23(2):73-82. doi: 10.1016/j.tem.2011.12.001. Epub 2012 Jan 16. Review.

PMID:
22257677
4.

A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.

Williams C, Edvardsson K, Lewandowski SA, Ström A, Gustafsson JA.

Oncogene. 2008 Feb 7;27(7):1019-32. Epub 2007 Aug 13.

PMID:
17700529
5.

Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.

Vazquez-Martin A, Cufí S, López-Bonet E, Corominas-Faja B, Cuyàs E, Vellon L, Iglesias JM, Leis O, Martín AG, Menendez JA.

Cell Cycle. 2013 Nov 15;12(22):3471-7. doi: 10.4161/cc.26692. Epub 2013 Oct 4.

6.

Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.

Mafuvadze B, Liang Y, Hyder SM.

Oncol Rep. 2014 Oct;32(4):1727-33. doi: 10.3892/or.2014.3332. Epub 2014 Jul 15.

PMID:
25051231
7.

RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.

Thaler S, Schmidt M, Schad A, Sleeman JP.

Oncogene. 2012 Nov 22;31(47):4912-22. doi: 10.1038/onc.2011.658. Epub 2012 Jan 23.

PMID:
22266866
9.

Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36).

Chaudhri RA, Olivares-Navarrete R, Cuenca N, Hadadi A, Boyan BD, Schwartz Z.

J Biol Chem. 2012 Mar 2;287(10):7169-81. doi: 10.1074/jbc.M111.292946. Epub 2012 Jan 13.

10.

SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.

Band AM, Laiho M.

Cell Signal. 2012 Apr;24(4):922-30. doi: 10.1016/j.cellsig.2011.12.015. Epub 2011 Dec 29.

11.

SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer.

Elangovan S, Ramachandran S, Venkatesan N, Ananth S, Gnana-Prakasam JP, Martin PM, Browning DD, Schoenlein PV, Prasad PD, Ganapathy V, Thangaraju M.

Cancer Res. 2011 Nov 1;71(21):6654-64. doi: 10.1158/0008-5472.CAN-11-1446. Epub 2011 Sep 15.

12.

Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.

Chang EC, Frasor J, Komm B, Katzenellenbogen BS.

Endocrinology. 2006 Oct;147(10):4831-42. Epub 2006 Jun 29.

PMID:
16809442
13.

Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.

Konduri SD, Medisetty R, Liu W, Kaipparettu BA, Srivastava P, Brauch H, Fritz P, Swetzig WM, Gardner AE, Khan SA, Das GM.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15081-6. doi: 10.1073/pnas.1009575107. Epub 2010 Aug 9.

14.

Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.

Chang EC, Charn TH, Park SH, Helferich WG, Komm B, Katzenellenbogen JA, Katzenellenbogen BS.

Mol Endocrinol. 2008 May;22(5):1032-43. doi: 10.1210/me.2007-0356. Epub 2008 Feb 7.

15.

Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator.

Liu X, An BH, Kim MJ, Park JH, Kang YS, Chang M.

Biochem Biophys Res Commun. 2014 Sep 26;452(3):840-4. doi: 10.1016/j.bbrc.2014.09.017. Epub 2014 Sep 16.

PMID:
25218501
16.

Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.

Lo R, Burgoon L, Macpherson L, Ahmed S, Matthews J.

Biochim Biophys Acta. 2010 May-Jun;1799(5-6):469-79. doi: 10.1016/j.bbagrm.2010.01.005. Epub 2010 Jan 14.

17.

Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.

Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K.

Cancer Res. 2007 Apr 15;67(8):3955-62.

18.

Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.

Sundar SN, Marconett CN, Doan VB, Willoughby JA Sr, Firestone GL.

Carcinogenesis. 2008 Dec;29(12):2252-8. doi: 10.1093/carcin/bgn214. Epub 2008 Sep 10.

19.
20.

Cracking the estrogen receptor's posttranslational code in breast tumors.

Le Romancer M, Poulard C, Cohen P, Sentis S, Renoir JM, Corbo L.

Endocr Rev. 2011 Oct;32(5):597-622. doi: 10.1210/er.2010-0016. Epub 2011 Jun 15. Review.

PMID:
21680538

Supplemental Content

Support Center